EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management

Dhweeja Dasarathy, Jeremy W Luk, Amy M Shui, Robert J Wong iD, Ramsey Cheung iD, Alexander Monto, Michael J Ostacher, Steven L Batki, Hannah R Snyder, Michael J Peluso, Derek Satre, Mandana Khalili iD

Alcohol and Alcoholism · 13.05.2026 · 61 (4)

DOI: 10.1093/alcalc/agag043 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alcohol and Alcoholism, online erschienen am 24.06.2026. Verfasst von Dhweeja Dasarathy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, United States. Hauptthemen laut MEDLINE: Quality of Life, Liver Cirrhosis, Alcoholic, COVID-19. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAAA NIH HHS, NIDDK NIH HHS, the Intramural Research Program of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patient-reported symptoms following COVID-19 exposure have been understudied in cirrhosis. This study evaluated type, severity, and persistence of symptoms along with impact on quality of life (QOL) post-SARS-CoV-2 infection in a cohort with and without alcohol-related cirrhosis.

Methods

Patients with cirrhosis receiving care in hepatology clinics at three institutions were surveyed for symptoms and liver disease QOL (LDQOL) using standardized instruments following SARS-CoV-2 infection. Acute (<30 days), post-acute (≥30 days since onset), and Long COVID (≥3 months) symptoms were compared by cirrhosis etiology and decompensated status. Associations between severe COVID-19 symptoms and LDQOL were examined using multivariable models.

Results

156 patients with prior COVID-19 exposure had a median age of 66.5 years; 18% were female; 43% had alcohol-related liver disease (ALD); and 42% decompensated cirrhosis. Among 208 surveys conducted, the median (Q1, Q3) number of symptoms reported was 6 (3, 10), with 66% reporting at least one severe/very severe symptom and 21% had Long COVID. There were no significant differences in symptoms by cirrhosis etiology or decompensation except those with ALD had higher post-acute symptoms compared to non-ALD (RR 2.17, P = .04). Moreover, the total number of severe symptoms was inversely associated with LDQOL. For each additional severe symptom reported, LDQOL decreased by 1.12 points after adjusting for age, sex, ALD, decompensated cirrhosis, and MELD-Na score (95% CI −1.70 to −0.53, P = .001).

Conclusions

Assessing severity and persistence of post-COVID-19 exposure symptoms can help clinicians address patient-reported QOL concerns, optimize cirrhosis management, and inform integrated care for ALD and AUD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeLiver Cirrhosis, AlcoholicCOVID-19HumansFemaleMaleAgedMiddle AgedPost-Acute COVID-19 SyndromeSeverity of Illness IndexSymptom BurdenSARS-CoV-2

Stichwörter der Autor:innen

alcohol-associated liver diseasecirrhosispatient-reported experiencespatient-reported symptomsquality of life

Autor:innen und Institutionen

  • Department of Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, United States.
  • Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, 10 Center Drive, Room 1-5330, Bethesda, MD 20892, United States.
  • Department of Epidemiology and Biostatistics, University of California, 550 16th Street, #2536, San Francisco, CA 94158, United States.
  • University of California San Francisco Liver Center, 513 Parnassus Avenue, San Francisco, CA 94143, United States.
  • Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304, United States.
  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, United States.

ORCID-Profile: Robert J Wong, Ramsey Cheung, Mandana Khalili

Förderung

  • NIAAA NIH HHS
  • NIDDK NIH HHS
  • the Intramural Research Program of the National Institutes of Health
  • National Institute of Alcohol Abuse and Alcoholism

Zitieren

APA

Dasarathy, D., Luk, J. W., Shui, A. M., Wong, R. J., Cheung, R., Monto, A., Ostacher, M. J., Batki, S. L., Snyder, H. R., Peluso, M. J., Satre, D., & Khalili, M. (2026). Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management. Alcohol and Alcoholism, 61(4). https://doi.org/10.1093/alcalc/agag043

Vancouver

Dasarathy D, Luk JW, Shui AM, Wong RJ, Cheung R, Monto A, et al. Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management. Alcohol and Alcoholism. 2026;61(4). doi:10.1093/alcalc/agag043

BibTeX
@article{Dasarathy2026,
  author = {Dasarathy, Dhweeja and Luk, Jeremy W and Shui, Amy M and Wong, Robert J and Cheung, Ramsey and Monto, Alexander and Ostacher, Michael J and Batki, Steven L and Snyder, Hannah R and Peluso, Michael J and Satre, Derek and Khalili, Mandana},
  title = {Evaluating acute and post-acute COVID-19 symptoms among patients with and without alcohol-related cirrhosis: implications for quality management},
  journal = {Alcohol and Alcoholism},
  year = {2026},
  volume = {61},
  number = {4},
  doi = {10.1093/alcalc/agag043}
}
Kostenlos starten →